• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Trex Medical completes public offering

Article

X-ray vendor Trex Medical this month completed a public stockoffering that raised net proceeds of $49.8 million. Trex, of Danbury,CT, issued 2.9 million shares of stock at $14 a share, includingan over-allotment option of 375,000 shares. The stock was

X-ray vendor Trex Medical this month completed a public stockoffering that raised net proceeds of $49.8 million. Trex, of Danbury,CT, issued 2.9 million shares of stock at $14 a share, includingan over-allotment option of 375,000 shares. The stock was tradingat about $20 a share in mid-July. Parent company ThermoTrex retainsan 80% stake in Trex Medical.

In other Trex Medical news, the company announced that it hassigned a preferred provider deal to supply mammography and stereotacticbiopsy equipment to the Columbia/HCA hospital chain. Columbia/HCAhospitals will be able to purchase Lorad and Bennett mammographysystems and upright stereotactic biopsy devices, as well as Lorad'sprone stereotactic biopsy table.

The deal puts Trex in privileged company: Columbia/HCA hasa close equipment purchasing relationship with GE Medical Systemsas part of the multivendor service and asset management relationshipbetween the companies (SCAN 3/29/95).

Trex Medical CEO Hal Kirshner also reported that Trex has ambitiousplans for the upcoming Radiological Society of North America meetingin December. The company will use the Trex Medical logo at itsbooth for the first time, with subsidiary companies like Lorad,Bennett, XRE, and Continental occupying separate sections of theexhibit.

"We're going to have a very big booth," Kirshnersaid.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.